Eli Lilly said Monday that it planned to cut 5,500 jobs, or 13.5 percent of its work force, in a restructuring meant to bolster the company as it girds for generic competition by late 2011 on its top-selling Zyprexa schizophenia drug.
Eli Lilly plans to cut 5,500 jobs